Portfolio Holdings Detail for ISIN IE000X08RX14
| Stock Name / Fund | iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | EDMNZx(NZD) CXE |
Holdings detail for CRL
| Stock Name | Creightons Plc |
| Ticker | CRL(GBX) LSE |
| TYPE | Common Stock |
| Country | UK |
| ISIN | GB0002341666 |
| LEI | 213800WROWAJUBGSAJ57 |
Show aggregate CRL holdings
News associated with CRL
- Raymond James Financial Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)
- Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 231,720 shares of the medical research company’s stock, valued at approximately $42,776,000. A number of other large investors have also added to or reduced their stakes in […] - 2025-03-13 08:35:38
- Assetmark Inc. Has $1.80 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
- Assetmark Inc. grew its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5,099.5% during the 4th quarter, Holdings Channel reports. The firm owned 9,775 shares of the medical research company’s stock after purchasing an additional 9,587 shares during the quarter. Assetmark Inc.’s holdings in Charles River Laboratories International were worth $1,804,000 […] - 2025-03-11 08:20:57
- Charles Schwab Investment Management Inc. Boosts Position in Charles River Laboratories International, Inc. (NYSE:CRL)
- Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […] - 2025-03-10 08:44:49
- 1,382 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by QRG Capital Management Inc.
- QRG Capital Management Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,382 shares of the medical research company’s stock, valued at approximately $255,000. Other hedge funds have also added to or reduced their stakes in the […] - 2025-03-07 09:30:55
- Charles River Laboratories International, Inc. (NYSE:CRL) Receives $198.36 Consensus Price Target from Brokerages
- Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average recommendation of “Hold” from the sixteen brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and one has given a buy rating to the company. The […] - 2025-03-07 08:38:58
- Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Redburn Atlantic
- Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by research analysts at Redburn Atlantic from a “sell” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $188.00 target price on the medical research company’s stock. Redburn Atlantic’s target price would suggest a potential […] - 2025-03-05 07:04:54
- Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?
- Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance. - 2025-02-26 14:55:35
- Insiders Pile Into Holdings of FTXH ETF
- A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (FTXH) shows an impressive 23.8% of holdings on a weighted basis have experienced insider buying within the past six months.
Charles River Laboratories International Inc. (Symbol: CRL), wh - 2025-02-26 14:32:53
- Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?
- Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance. - 2025-02-26 12:36:14
- Charles River Laboratories International (NYSE:CRL) Shares Up 3.9% on Insider Buying Activity
- Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report)’s stock price rose 3.9% during trading on Monday after an insider bought additional shares in the company. The stock traded as high as $172.45 and last traded at $169.45. Approximately 274,567 shares were traded during trading, a decline of 73% from the average daily volume […] - 2025-02-25 06:05:00
- Charles River Laboratories International (NYSE:CRL) Shares Gap Up After Better-Than-Expected Earnings
- Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $154.39, but opened at $159.28. Charles River Laboratories International shares last traded at $160.76, with a volume of 152,366 shares changing […] - 2025-02-21 06:56:44
- Barclays Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $166.00
- Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target cut by equities research analysts at Barclays from $205.00 to $166.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 0.61% from […] - 2025-02-20 06:58:45
- Charles River Laboratories Q4 24 Earnings Conference Call At 8:30 AM ET
- (RTTNews) - Charles River Laboratories International Inc. (CRL) will host a conference call at 8:30 AM ET on February 19, 2025, to discuss Q4 24 earnings results. - 2025-02-19 12:31:18
- Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by New York State Teachers Retirement System
- New York State Teachers Retirement System decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,230 shares of the medical research company’s stock after selling […] - 2025-02-19 10:44:53
- Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Decreased by Louisiana State Employees Retirement System
- Louisiana State Employees Retirement System cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,800 shares of the medical research company’s stock after selling 100 […] - 2025-02-19 10:10:54
- Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by V Square Quantitative Management LLC
- V Square Quantitative Management LLC raised its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,084 shares of the medical research company’s stock after buying an additional 121 shares during the quarter. V Square […] - 2025-02-18 09:28:57
- Chevy Chase Trust Holdings LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)
- Chevy Chase Trust Holdings LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,834 shares of the medical research company’s stock after selling 849 shares during […] - 2025-02-18 08:44:51
- Van ECK Associates Corp Has $8.93 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
- Van ECK Associates Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,380 shares of the medical research company’s stock after selling 2,893 shares during the quarter. […] - 2025-02-17 08:49:11
- Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Stratos Wealth Partners LTD.
- Stratos Wealth Partners LTD. decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 17.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,523 shares of the medical research company’s stock after selling 314 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Charles River Laboratories International were worth […] - 2025-02-14 09:00:50
- abrdn plc Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
- abrdn plc cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,817 shares of the medical research company’s stock after selling 1,027 shares during the quarter. abrdn plc’s […] - 2025-02-10 18:43:00
- Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mather Group LLC.
- Mather Group LLC. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 20.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 358 shares of the medical research company’s stock after selling 91 shares during the quarter. Mather […] - 2025-02-08 08:44:51
- Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of “Reduce” from Analysts
- Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the seventeen analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and one has given a buy rating […] - 2025-02-07 08:28:37
- Tokio Marine Asset Management Co. Ltd. Buys 485 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
- Tokio Marine Asset Management Co. Ltd. increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 24.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,463 shares of the medical research company’s stock after purchasing an additional […] - 2025-02-05 08:48:53
- Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Up 5.6% in January
- Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 2,260,000 shares, an increase of 5.6% from the December 31st total of 2,140,000 shares. Based on an average daily volume of 667,300 shares, the […] - 2025-02-03 06:32:58
- 1,282 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Flagship Harbor Advisors LLC
- Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,282 shares of the medical research company’s stock, valued at approximately $237,000. Several other institutional investors have also […] - 2025-01-30 09:43:30
iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) CRL holdings
| Date | Number of CRL Shares Held | Base Market Value of CRL Shares | Local Market Value of CRL Shares | Change in CRL Shares Held | Change in CRL Base Value | Current Price per CRL Share Held | Previous Price per CRL Share Held |
|---|
| 2024-11-08 (Friday) | 958 | USD 206,344 | USD 206,344 | 0 | USD 4,886 | USD 215.39 | USD 210.29 |
| 2024-11-07 (Thursday) | 958 | USD 201,458 | USD 201,458 | 0 | USD -3,746 | USD 210.29 | USD 214.2 |
| 2024-11-06 (Wednesday) | 958 | USD 205,204 | USD 205,204 | 0 | USD 24,449 | USD 214.2 | USD 188.68 |
| 2024-11-05 (Tuesday) | 958 | USD 180,755 | USD 180,755 | 0 | USD 5,939 | USD 188.68 | USD 182.48 |
| 2024-11-04 (Monday) | 958 | USD 174,816 | USD 174,816 | 0 | USD 1,456 | USD 182.48 | USD 180.96 |
| 2024-11-01 (Friday) | 958 | USD 173,360 | USD 173,360 | -16 | USD -577 | USD 180.96 | USD 178.58 |
| 2024-10-31 (Thursday) | 974 | USD 173,937 | USD 173,937 | 0 | USD -2,737 | USD 178.58 | USD 181.39 |
| 2024-10-30 (Wednesday) | 974 | USD 176,674 | USD 176,674 | 0 | USD -2,542 | USD 181.39 | USD 184 |
| 2024-10-29 (Tuesday) | 974 | USD 179,216 | USD 179,216 | 0 | USD -2,454 | USD 184 | USD 186.52 |
| 2024-10-28 (Monday) | 974 | USD 181,670 | USD 181,670 | 0 | USD 4,285 | USD 186.52 | USD 182.12 |
| 2024-10-25 (Friday) | 974 | USD 177,385 | USD 177,385 | 0 | USD -594 | USD 182.12 | USD 182.73 |
| 2024-10-24 (Thursday) | 974 | USD 177,979 | USD 177,979 | 0 | USD -3,799 | USD 182.73 | USD 186.63 |
| 2024-10-23 (Wednesday) | 974 | USD 181,778 | USD 181,778 | 0 | USD 672 | USD 186.63 | USD 185.94 |
| 2024-10-22 (Tuesday) | 974 | USD 181,106 | USD 181,106 | 0 | USD -8,863 | USD 185.94 | USD 195.04 |
| 2024-10-21 (Monday) | 974 | USD 189,969 | USD 189,969 | 0 | USD -2,659 | USD 195.04 | USD 197.77 |
| 2024-10-18 (Friday) | 974 | USD 192,628 | USD 192,628 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of CRL by Blackrock for IE000X08RX14
Show aggregate share trades of CRL| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2024-11-01 | SELL | -16 | | | 180.960* | | 184.77 Profit of 2,956 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of CRL
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-12 | 251,248 | 0 | 325,363 | 77.2% |
| 2025-03-11 | 315,061 | 0 | 397,387 | 79.3% |
| 2025-03-10 | 234,622 | 0 | 371,825 | 63.1% |
| 2025-03-07 | 267,427 | 137 | 418,398 | 63.9% |
| 2025-03-06 | 220,192 | 0 | 321,914 | 68.4% |
| 2025-03-05 | 129,505 | 0 | 251,515 | 51.5% |
| 2025-03-04 | 176,937 | 449 | 404,282 | 43.8% |
| 2025-03-03 | 306,321 | 1,182 | 537,622 | 57.0% |
| 2025-02-28 | 422,297 | 1,410 | 541,306 | 78.0% |
| 2025-02-27 | 550,064 | 131 | 739,921 | 74.3% |
| 2025-02-26 | 392,086 | 701 | 512,753 | 76.5% |
| 2025-02-25 | 479,967 | 50 | 666,159 | 72.0% |
| 2025-02-24 | 451,612 | 4 | 561,131 | 80.5% |
| 2025-02-21 | 313,182 | 1 | 397,062 | 78.9% |
| 2025-02-20 | 474,304 | 20 | 656,987 | 72.2% |
| 2025-02-19 | 633,738 | 24 | 892,706 | 71.0% |
| 2025-02-18 | 417,756 | 15 | 692,442 | 60.3% |
| 2025-02-14 | 217,938 | 0 | 316,662 | 68.8% |
| 2025-02-13 | 192,661 | 40 | 332,878 | 57.9% |
| 2025-02-12 | 285,395 | 0 | 573,492 | 49.8% |
| 2025-02-11 | 176,430 | 5 | 348,302 | 50.7% |
| 2025-02-10 | 213,330 | 37 | 411,164 | 51.9% |
| 2025-02-07 | 133,481 | 92 | 202,124 | 66.0% |
| 2025-02-06 | 161,096 | 12 | 603,999 | 26.7% |
| 2025-02-05 | 156,616 | 280 | 310,919 | 50.4% |
| 2025-02-04 | 314,334 | 30 | 943,864 | 33.3% |
| 2025-02-03 | 179,062 | 0 | 298,406 | 60.0% |
| 2025-01-31 | 122,138 | 145 | 284,338 | 43.0% |
| 2025-01-30 | 176,382 | 0 | 333,185 | 52.9% |
| 2025-01-29 | 134,820 | 250 | 220,537 | 61.1% |
| 2025-01-28 | 103,430 | 672 | 236,231 | 43.8% |
| 2025-01-27 | 118,658 | 0 | 335,044 | 35.4% |
| 2025-01-24 | 135,200 | 13,800 | 310,554 | 43.5% |
| 2025-01-23 | 186,562 | 0 | 399,224 | 46.7% |
| 2025-01-22 | 140,196 | 388 | 351,879 | 39.8% |
| 2025-01-21 | 275,465 | 0 | 478,658 | 57.5% |
| 2025-01-17 | 227,333 | 173 | 362,964 | 62.6% |
| 2025-01-16 | 1,061,817 | 5 | 1,479,033 | 71.8% |
| 2025-01-15 | 336,416 | 21 | 475,397 | 70.8% |
| 2025-01-14 | 415,332 | 38 | 735,591 | 56.5% |
| 2025-01-13 | 157,263 | 0 | 210,598 | 74.7% |
| 2025-01-10 | 252,599 | 34 | 310,828 | 81.3% |
| 2025-01-08 | 154,117 | 0 | 189,156 | 81.5% |
| 2025-01-07 | 239,509 | 22 | 302,405 | 79.2% |
| 2025-01-06 | 192,036 | 11 | 285,191 | 67.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.